Cellecta - HT RNAi Screens, Pooled Lentiviral shRNA Libraries Cellecta develops advanced high-throughput RNAi technologies and applications for the discovery and functional characterization of novel therapeutic targets and drugs. Our contract and collaborative research includes performing HT RNAi and peptide genetic screens, constructing pooled lentiviral shRNA and peptide libraries, and developing stable overexpression, knockdown, or reporter cell lines. Cellecta.net~Site InfoWhoisTrace RouteRBL Check
BioGenova: We specialize in particular technologies. Biogenova is a privately owned Biotechnology Company consisting of a group of highly motivated and trained scientists and business people. We specialize in particular technologies. Our goal is to provide our years of experience to the public and enable researchers to not only conduct R&D more efficiently and low cost but with rapid turnaround time. Biogenova.com~Site InfoWhoisTrace RouteRBL Check
The DECIPHER Project - An Open Source RNAi Screening Platform The objectives of the open source DECIPHER project are to provide academic labs with free tools to perform and analyze comprehensive shRNA knockdown screens and to develop a standardized yet versatile platform for collecting and comparing results from different studies and labs Decipherproject.net~Site InfoWhoisTrace RouteRBL Check
